Germ-Line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2

Cancer Genetics and Cytogenetics

Volumn 112, Issue 1, 1999, Pages 9-14

  Huusko, Pia ^a,b   Castrén, Katariina ^c   Launonen, Virpi ^a   Soini, Ylermi ^b   Pääkkönen, Kati ^a   Leisti, Jaakko ^a   Vähäkangas, Kirsi ^c   Winqvist, Robert ^a,b  

^a Department of Clinical Genetics ^*  (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; EXON; FAMILIAL CANCER; FEMALE; FINLAND; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

BRCA2 PROTEIN; FEMALE; FINLAND; GENES, BRCA1; GENES, P53; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; NEOPLASM PROTEINS; NEOPLASMS; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS;

EID: 0033167278     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00258-1     Document Type: Article

References (33)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P.K., Norris F.H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G., Barfoot R., Hamoudi M., Patel S., Rice C., Biggs P., Hashim Y., Smith A., Connor F., Arason A., Gudmundsson J., Ficenec D., Kelsell D., Ford D., Tonin P., Bishop D.T., Spurr N.K., Ponder B.A.J., Eeles R., Peto J., Devilee P., Cornelisse C., Lynch H., Narod S., Lenoir G., Egilsson V., Barkardottir R.B., Easton D.F., Bentley D.R., Futreal P.A., Ashworth A., Stratton M.R. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
3. Huusko P., Pääkkönen K., Launonen V., Pöyhönen M., Blanco G., Kauppila A., Puistola U., Kiviniemi H., Kujala M., Leisti J., Winqvist R. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. Am J Hum Genet. 62:1998;1544-1548.
4. Vehmanen P., Friedman L.S., Eerola H., McClure M., Ward B., Sarantaus L., Kainu T., Syrjäkoski K., Pyrhönen S., Kallioniemi O.-P., Muhonen T., Luce M., Frank T.S., Nevanlinna H. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families. evidence for additional susceptibility genes Hum Mol Genet. 6:1997;2309-2315.
5. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A., Friend S.H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233-1238.
6. Srivastava S., Zou Z., Pirollo K., Blattner W., Chang E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 348:1990;747-749.
7. Wooster R., Mangion J., Eeles R., Smith S., Dowsett M., Averill D., Barrett-Lee P., Easton D.F., Ponder B.A.J., Stratton M.R. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet. 2:1992;132-134.
8. Swift M., Reitnauer P.J., Morrell D., Chase C.L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med. 316:1987;1289-1294.
9. Tsou H.C., Teng D.H.-F., Ping X.L., Brancolini V., Davis T., Hu R., Xie X.X., Gruener A.C., Schrager C.A., Christiano A.M., Eng C., Steck P., Ott J., Tavtigian S.V., Peacocke M. The role of MMAC1 mutations in early-onset breast cancer. causative in association with Cowden syndrome and excluded in BRCA1-negative cases Am J Hum Genet. 61:1997;1036-1043.
10. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Höglund P., Järvinen H., Kristo P., Pelin K., Ridanpää M., Salovaara R., Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R., de la Chapelle A., Aaltonen L.A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:1998;184-187.
11. Li F.P., Fraumeni J.F. Soft-tissue sarcomas, breast cancer, and other neoplasms. a familial syndrome? Ann Intern Med. 71:1969;747-752.
12. Garber J.E., Goldstein A.M., Kantor A.F., Dreyfus M.G., Fraumeni J.F., Li F.P. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res. 51:1991;6094-6097.
13. Li F.P., Fraumeni J.F., Mulvihill J.J., Blattner W.A., Dreyfus M.G., Tucker M.A., Miller R.W. A cancer family syndrome in twenty-four kindreds. Cancer Res. 48:1988;5358-5362.
14. Birch J.M., Harley A.L., Tricker K.J., Prosser J., Condie A., Kelsey A.M., Harris M., Morris Jones P.H., Binchy A., Crowther D., Craft A.W., Eden O.B., Evans D.G.R., Thompson E., Mann J.R., Martin J., Mitchell E.L.D., Santibáñez-Koref M.F. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 54:1994;1298-1304.
15. Eng C., Schneider K., Fraumeni J.F., Li F.P. Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. Cancer Epidemiol Biomarkers Prev. 6:1997;379-383.
16. Kleihues P., Schäuble B., zur Hausen A., Estève J., Ohgaki H. Tumors associated with p53 germline mutations. a synopsis of 91 families Am J Pathol. 150:1997;1-13.
17. Børresen A.-L., Andersen T.I., Garber J., Barbier-Piraux N., Thorlacius S., Eyfjörd J., Ottestad L., Smith-Sørensen B., Hovig E., Malkin D., Friend S.H. Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 52:1992;3234-3236.
18. Sidransky D., Tokino T., Helzlsouer K., Zehnbauer B., Rausch G., Shelton B., Prestigiacomo L., Vogelstein B., Davidson N. Inherited p53 gene mutations in breast cancer. Cancer Res. 52:1992;2984-2986.
19. Jolly K.W., Malkin D., Douglass E.C., Brown T.F., Sinclair A.E., Look A.T. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene. 9:1994;97-102.
20. Sun X.-F., Johannsson O., Håkansson S., Sellberg G., Nordenskjöld B., Olsson H., Borg Å A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene. 13:1996;407-411.
21. Cornelis R.S., van Vliet M., van de Vijver M.J., Vasen H.F.A., Voute P.A., Top B., Meera Khan P., Devilee P., Cornelisse C.J. Three germline mutations in the TP53 gene. Hum Mutat. 9:1997;157-163.
22. Prosser J., Elder P.A., Condie A., MacFadyen I., Steel C.M., Evans H.J. Mutations in p53 do not account for heritable breast cancer. a study in five affected families Br J Cancer. 63:1991;181-184.
23. Warren W., Eeles R.A., Ponder B.A.J., Easton D.F., Averill D., Ponder M.A., Anderson K., Evans A.M., DeMars R., Love R., Dundas S., Stratton M.R., Trowbridge P., Cooper C.S., Peto J. No evidence for germ-line mutations in exons 5-9 of the p53 gene in 25 breast cancer families. Oncogene. 7:1992;1043-1046.
24. Zelada-Hedman M., Børresen-Dale A.-L., Claro A., Chen J., Skoog L., Lindblom A. Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. Br J Cancer. 75:1997;1201-1204.
25. Lidereau R., Soussi T. Absence of p53 germ-line mutations in bilateral breast cancer patients. Hum Genet. 89:1992;250-252.
26. Lehman T.A., Bennett W.P., Metcalf R.A., Welsh J.A., Ecker J., Modali R.V., Ullrich S., Romano J.W., Appella E., Testa J.R., Gerwin B.I., Harris C.C. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:1991;4090-4096.
27. Welsh J.A., Castrén K., Vähäkangas K.H. Single strand conformation polymorphism (SSCP) analysis for detecting mu-tations within the p53 tumor suppressor gene. characterization and development of standards Clin Chem. 43:1997;2251-2255.
28. Vähäkangas K.H., Samet J.M., Metcalf R.A., Welsh J.A., Bennett W.P., Lane D.P., Harris C.C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet. 339:1992;576-580.
29. Launonen V, Stenbäck F, Puistola U, Bloigu R, Huusko P, Kytölä S, Kauppila A, Winqvist R (in press): Chromosome 11q22.3-q25 LOH in ovarian cancer: association to a more aggressive disease course and involved subregions. Gynecol Oncol.
30. Mazars G.R., Jeanteur P., Lynch H.T., Lenoir G., Theillet C. Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene. Oncogene. 7:1992;781-782.
31. Diller L., Sexsmith E., Gottlieb A., Li F.P., Malkin D. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest. 95:1995;1606-1611.
32. Varley J.M., Evans D.G.R., Birch J.M. Li-Fraumeni syndrome - a molecular and clinical review. Br J Cancer. 76:1997;1-14.
33. Garber J.E., Burke E.M., Lavally B.L., Billett A.L., Sallan S.E., Scott R.M., Kupsky W., Li F.P. Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 66:1990;2658-2660.